- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02655406
COmpressioN Following Endovenous TreatmenT of Incompetent Varicose Veins (CONFETTI)
COmpressioN Following Endovenous TreatmenT of Incompetent Varicose Veins (CONFETTI)
This study will be looking at the effect of compression therapy in patients having endovenous treatment for varicose veins using foam sclerotherapy. Patients will be randomised to either the compression group (group A) or the no compression group (group B).
The pain scores, compliance, quality of life scores, occlusion rate at 6 months as well as the cost effectiveness of each intervention will be assessed.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a randomised clinical trial looking at the impact of wearing or not wearing compression stocking following endovenous ablation using foam sclerotherapy.
Patients will be randomised to group A (compression) and group B (no compression).
Target Population Patients referred to the Imperial College NHS Trust for treatment of symptomatic varicose veins will be recruited if they are found to have varicose veins suitable for foam sclerotherapy on colour duplex scan.
Intervention
Patients will be randomised to have compression (group A) or no compression (group B). This will be done by using an online randomisation software (Sealed Envelope Ltd).
The compression therapy used will be Class II compression stockings. The treatment offered will be foam sclerotherapy of varicose veins using either Polidocanol or Sodium Tetradecyl Sulphate (STS) with the concentration used left to the discretion of the clinician.
Patients randomised to group A will be asked to wear compression stockings for 1 week.
Patients randomised to group B will be provided with bandages to wear for 24 hours only, with no further compression afterwards.
At baseline, patients will be asked to fill validated quality of life questionnaires (EQ-5D, AVVQ and CIVIQ) and will have their clinical scores assessed using a validated scoring system (CEAP and VCSS). On discharge after their varicose vein intervention, they will then be provided with a diary to record their post-procedural pain every day for 10 days using a validated visual analogue scale (VAS) as well as to record when they return to their normal activities and are back to work. They will also be asked to attend a follow-up in 2 weeks and at 6 months.
Patients' GP will also be sent a letter to inform them of their patient's participation in the study.
Follow-up
Patients will be followed up in the outpatient clinic at 2 weeks and 6 months.
Follow-up at 2 Weeks
At the 2 weeks' follow-up, the diary containing details of the pain scores and how soon patients were able to return to normal activities/work will be collected. In addition, patients will be asked about any phlebitis they have had in the two weeks after their procedure and how compliant they have been with the compression. They will be examined and the Venous Clinical Severity Score (VCSS) will be recorded. They will also be asked to fill in the EQ-5D, AVVQ and CIVIQ scores.
Follow-up at 6 Months
At the 6 months follow-up, patients will be examined and their VCSS will be recorded. They will also be asked to fill the EQ-5D, AVVQ and the CIVIQ scores. They will have a venous Duplex scan to determine occlusion of the treated vein.
Sample Size and Study Duration
We estimated the sample size needed to observe a difference of at least 10mm in the VAS score, with a standard deviation of 20mm. With power at 80% and 5% significance equivalence, we would need to recruit 128 patients (64 per group) to show a difference.
Previous studies looking at compression stockings have shown drop out rates close to 37% at 3 months10. Therefore, if we estimate a drop out rate of about 40% by 6 months, we would need to recruit at least 180 patients. If we recruit at least 2 patients per week, this will be approximately a total of 208 patients that could potentially be randomised over the course of two years.
With 6 months follow-up, therefore, the study will be running for 24 months with a target recruitment of 180 patients.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, W6 8RF
- Charing Cross Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults over 18 years of age
- Varicose veins suitable for foam sclerotherapy
Exclusion Criteria:
- Allergic to sclerosant
- Current DVT
- Arterial disease (ABPI<0.8)
- Patients unable to wear compression stockings
- Patients who are unwilling to participate
- Inability or unwillingness to complete questionnaires
- Inability to attend follow-up appointments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Compression stockings
Patients randomised to group A will be asked to wear compression stockings for 1 week
|
|
No Intervention: No compression
Patients randomised to group B will be provided with bandages to wear for 24 hours only, with no further compression afterwards
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient's pain score post-procedure using a visual analogue scale (VAS)
Time Frame: 10 days
|
Pain score
|
10 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Aberdeen Varicose Vein Questionnaire (AVVQ) score
Time Frame: 6 months
|
Disease-specific quality of life score
|
6 months
|
Chronic venous insufficiency (CIVIQ) score
Time Frame: 6 months
|
Disease-specific quality of life score
|
6 months
|
EuroQol's EQ-5D
Time Frame: 6 months
|
Generic quality of life score
|
6 months
|
Venous clinical severity score (VCSS)
Time Frame: 6 months
|
Clinical
|
6 months
|
Occlusion rate
Time Frame: 6 months
|
Occlusion rates will be assessed based on a pre-agreed scale
|
6 months
|
Degree of phlebitis
Time Frame: 6 months
|
Extent of phlebitis will be recorded using a scale
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Roshan Bootun, Imperial College London
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15/NE/0314
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Varicose Veins
-
EMSWithdrawn
-
EMSWithdrawn
-
Helsinki University Central HospitalActive, not recruiting
-
I-VASC S.r.lRecruiting
-
Acotec Scientific Co., LtdZhejiang UniversityCompletedVaricose Veins of Lower LimbChina
-
Beijing Tsinghua Chang Gung HospitalActive, not recruiting
-
Oulu University HospitalCompletedVaricose Veins | Varicose Veins of Lower LimbFinland
-
Kahramanmaras Sutcu Imam UniversityUnknown
-
The Fourth Affiliated Hospital of Zhejiang University...RecruitingVaricose Veins of Lower LimbChina
-
Worcestershire Acute Hospitals NHS TrustCompletedVaricose Veins of Lower LimbUnited Kingdom
Clinical Trials on Class 2 compression stockings
-
University Hospital ErlangenCompletedVascular Diseases | Vascular Malformations | Venous Malformation | Vascular Malformation PeripheralGermany
-
Oulu University HospitalCompletedVaricose VeinsFinland
-
Oulu University HospitalCompletedVaricose Veins | Varicose Veins of Lower LimbFinland
-
Imperial College LondonCompleted
-
University Hospital, GhentKom Op Tegen Kanker; University Hospital, LouvainRecruiting
-
University of WashingtonLake Washington Vascular; Sigvaris, IncUnknownVaricose VeinsUnited States
-
Imperial College LondonNational Institute for Health Research, United KingdomNot yet recruitingSurgery | Venous Thromboembolism
-
Federal University of São PauloUnknownQuality of Life | Cellulitis
-
Singapore General HospitalNational University of Ireland, Galway, IrelandUnknownVaricose Veins | Chronic Venous InsufficiencySingapore, Ireland
-
Johns Hopkins UniversitySigvaris CorporationCompletedVenous InsufficiencyUnited States